Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection

Thorax

Volumn 59, Issue 8, 2004, Pages 704-707

  Breen, R A M ^a   Smith, C J ^b   Bettinson, H ^a   Dart, S ^a   Bannister, B ^a   Johnson, M A ^a   Lipman, M C I ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CORTICOSTEROID; PREDNISOLONE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STEROID; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 4043161940     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2003.019224     Document Type: Article

References (18)

1. Chloremis CD, Padiatellis C, Zoumbaulakis D, et al. Transitory exacerbation of fever and roentgenographic findings during treatment of tuberculosis in children. Am Rev Tuberc 1955;72:527-36.
2. Silver CP, Steel SJ. Mediastinal lymphatic gland tuberculosis in Asian and coloured immigrants. Lancet, 1961;i, 1254-6.
3. Campbell IA, Dyson AJ. Lymph node tuberculosis: a comparison of various methods of treatment. Tubercle 1977;58:171-9.
4. Onwubalili JK, Scott GM, Smith H. Acute respiratory distress related to chemotherapy of advanced pulmonary tuberculosis: a study of two cases and review of the literature. Q J Med 1986;59:599-610.
5. Narita M, Ashkin D, Hollender ES, et al. Paradoxical worsening of tuberculosis following anti-retroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998;158:157-61.
6. Barry SM, Lipman MCI, Deery AR, et al. Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects. HIV Med 2002;3:207-11.
7. Race EM, Adelson-Mitty J, Kriegel GR, et al. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor tnerapy in patients with adanced HIV-1 disease. Lancet 1998;351:252-5.
8. Zegans ME, Walton RC, Holland GN, et al. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol 1998;125:292-300.
9. Wendel KA, Alwood KS, Gachuhi R, et al. Paradoxical worsening of tuberculosis in HIV-infected persons. Chest 2001;120:193-7.
10. Navas E, Martin-Davila P, Moreno L, et al. Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy. Arch Intern Med 2002;162:97-9.
11. Barry SM, Lipman MCI, Bannister B, et al. Purified protein derivative-activated type 1 cytokine-producing CD4+ T lymphocytes in the lung: a characteristic feature of active pulmonary and non-pulmonary TB. J Infect Dis 2003;187:243-50.
12. Li TS, Tubiana R, Katlama C, et al. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998;351:1682-6.
13. Schluger NW, Perez D, Liu YM. Reconstitution of immune responses to tuberculosis in patients with HIV infection who receive antiretroviral therapy. Chest 2002;122:597-602.
14. Dean GL, Edwards SG, Ives NJ, et al. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS 2002;16:75-83.
15. Rooney JJ, Crocco JA, Kramer S, et al. Further observations of tuberculin reactions in active tuberculosis. Am J Med 1976;60:517-22.
16. Watzl B, Watson RR. Role of alcohol abuse in nutritional immunosuppression. J Nutr 1992;122:733-7.
17. Elliott AM, Luo N, Tembo G, et al. Impact of HIV on tuberculosis in Zambia: a cross sectional study. BMJ 1990;301:412-5.
18. Koch R. Weitere Mittheilungen uber ein Heilmittel gegen Tuberculose. Dtsch Med Wochenschr 1890;16:1029.